Chronic Uveitis

A validated prognostic tool using common clinical markers could help clinicians evaluate patients with juvenile idiopathic arthritis for chronic uveitis risk, according to data published in Arthritis & Rheumatology.

NEW YORK — In this Healio Video Perspective from the ASRS meeting, Christopher R. Henry, MD, discusses results from a post hoc analysis of the phase 3 PEACHTREE study.

A real-world efficacy study of EyePoint Pharmaceuticals’ Yutiq fluocinolone implant in eyes with chronic noninfectious uveitis demonstrated stable visual acuity trending toward improvement at 6 months, according to a presenter.

Opacity limiting the surgeon’s view of the posterior segment was the leading cause for IOL removal during vitreoretinal surgery, according to a study.